Grand Pharma
Grand Pharma (also known as Grand Pharmaceutical Group Limited) is a prominent player in the pharmaceutical industry, headquartered in China (CN). Established in 1998, the company has made significant strides in the development, manufacturing, and distribution of innovative healthcare solutions across various operational regions, including Asia and beyond. Specialising in prescription drugs, over-the-counter medications, and active pharmaceutical ingredients, Grand Pharma distinguishes itself through its commitment to quality and research-driven approaches. The company has achieved notable milestones, including strategic partnerships and a robust portfolio of unique products that cater to diverse therapeutic areas. With a strong market position, Grand Pharma is recognised for its contributions to healthcare, consistently striving to enhance patient outcomes and expand its global footprint.
DitchCarbon Score
How does Grand Pharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Grand Pharma's score of 2 is higher than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Grand Pharma's reported carbon emissions
In 2021, Grand Pharma reported total carbon emissions of approximately 276,000,000 kg CO2e, comprising about 172,000,000 kg CO2e from Scope 1 emissions and about 104,000,000 kg CO2e from Scope 2 emissions. The company has not disclosed any specific reduction targets or initiatives under the Science Based Targets initiative (SBTi) or other climate pledges. As a global entity headquartered in China, Grand Pharma is positioned within an industry increasingly focused on sustainability and carbon footprint reduction, yet specific commitments or achievements in this area remain unspecified.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2021 | |
|---|---|
| Scope 1 | 172,000,000 |
| Scope 2 | 104,000,000 |
| Scope 3 | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Grand Pharma is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
